SCHEMBL7644398

SCHEMBL7644398

COC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)Nc1nc(-c2ccccc2)ns1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.45
ADORA3 P0DMS8 5/20 0.44
TP53 P04637 2/20 0.44
ALOX15 P16050 1/20 0.44
MAPK1 P28482 1/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
HSD17B10 Q99714 1/20 0.44
SMN1; SMN2 Q16637 5/20 0.43
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
LMNA P02545 3/20 0.43
ACE P12821 2/20 0.43
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 1/20 0.39
IDO1 P14902 1/20 0.39
FPR3 P25089 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28746793 1.00 CNR2 (0.45) CNR2ADORA3TP53ALOX15MAPK1
SCHEMBL7400095 0.92 ACE (0.51) CNR2ADORA3TP53ALOX15MAPK1
SCHEMBL7642022 0.85 PEPD (0.39) CNR2SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL27554019 0.85 PEPD (0.39) CNR2SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL7646534 0.84 PEPD (0.39) CNR2SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL7640465 0.83 PEPD (0.38) CNR2SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL27556964 0.83 PEPD (0.38) CNR2SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL7546728 0.81 ACE (0.38) CNR2NPC1RAB9AACEHTT
SCHEMBL27569196 0.81 ACE (0.38) CNR2NPC1RAB9AACEHTT
SCHEMBL7598645 0.79 ALDH1A1 (0.46) MAPK1HSD17B10SMN1; SMN2NPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6468977-B1 COMPOUNDS USEFUL IN TREATMENT TREATMENT OF DISORDER AND/OR DISEASE CAUSED BY ACTIVITY OF ENZYMES SUCH AS HUMAN RHINOVIRUS 3C PROTEASE, TRANSGLUTAMINASE AND CATHEPSINS APOTEX INC. (CA) 2002-10-22 US disclosed
CN-1291993-A Thiadiazole compounds useful as cysteine activity dependent enzyme inhibitors APOTEX INC (CA) 2001-04-18 CN disclosed
US-6162791-A Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes APOTEX INC. (CA) 2000-12-19 US disclosed